Snowball will help you to track your portfolio, plan deposits to your brokerage account and support your passive income strategy with tools and community of investors
What sector does Shanghai Fosun Pharmaceutical Group Co Ltd (2196) operate in?
Shanghai Fosun Pharmaceutical Group Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Shanghai Fosun Pharmaceutical Group Co Ltd (2196) current stock price?
As of the latest data, Shanghai Fosun Pharmaceutical Group Co Ltd stock price is HK$17.02, with a previous close of HK$16.92. Shanghai Fosun Pharmaceutical Group Co Ltd gained HK$0.10 in the last trading session, representing a 0.59% increase.
What is Shanghai Fosun Pharmaceutical Group Co Ltd (2196) current market capitalization?
Shanghai Fosun Pharmaceutical Group Co Ltd market cap is approximately 9.39 billion.
What is Shanghai Fosun Pharmaceutical Group Co Ltd (2196) Earnings Per Share (EPS)?
The trailing EPS is HK$1.11.
What is Shanghai Fosun Pharmaceutical Group Co Ltd (2196) Price-to-Earnings (P/E) ratio?
Shanghai Fosun Pharmaceutical Group Co Ltd current P/E ratio is 15.4.
Does Shanghai Fosun Pharmaceutical Group Co Ltd (2196) pay dividends?
Yes. Shanghai Fosun Pharmaceutical Group Co Ltd pays annual dividends with an annualized yield of 1.76% and an estimated annual payout of HK$0.30 per share.
When is the next ex-dividend date for Shanghai Fosun Pharmaceutical Group Co Ltd (2196)?
The next ex-dividend date is scheduled for July 26, 2025.
How did Shanghai Fosun Pharmaceutical Group Co Ltd (2196) perform in its most recent earnings report?
In the last report (March 31, 2025), Shanghai Fosun Pharmaceutical Group Co Ltd posted an EPS surprise of -3.33% and a revenue surprise of -2.15%.
When is Shanghai Fosun Pharmaceutical Group Co Ltd (2196) next earnings report?
Shanghai Fosun Pharmaceutical Group Co Ltd is expected to release its next earnings report on June 30, 2025.
What is Shanghai Fosun Pharmaceutical Group Co Ltd (2196) beta (volatility) score?
Shanghai Fosun Pharmaceutical Group Co Ltd has a beta of 1.183, meaning its volatility is roughly in line with the market.
